Objectives-To evaluate the completeness of notifications of Down's syndrome live births and terminations to the Office for National Statistics (ONS) using data from the National Down Syndrome Cytogenetic Register (NDSCR). To examine the agreement of observed birth prevalence of Down's syndrome with the expected birth prevalence derived from published maternal age specific rates. Methods-The number of live births (adjusted to allow for the estimated underascertainment) and the number of terminations due to fetal Down's syndrome from NDSCR were compared with those figures reported to the ONS. Subsequently, using the NDSCR figures, the live birth prevalence of Down's syndrome that would have occurred in the absence of antenatal diagnosis and selective termination was calculated in England and Wales in the years 1990-1993. These figures were compared with those derived by applying published age specific prevalences to the maternal age distribution in England and Wales. Results-It is estimated that only 48% and 46% respectively of Down's syndrome live births and terminations of pregnancy were notified to ONS between 1990 and 1993. The annual expected birth prevalences of Down's syndrome obtained by applying maternal age specific prevalences to the maternal age distribution were in close agreement with observed rates from NDSCR. Conclusions-There is considerable underreporting of Down's syndrome births and terminations to ONS. The NDSCR data are more complete and therefore the effects of screening should be monitored using data from this source, or using estimates derived from the age specific rates of Down's syndrome.
Abstract
Objectives-To evaluate the completeness of notifications of Down's syndrome live births and terminations to the Office for National Statistics (ONS) using data from the National Down Syndrome Cytogenetic Register (NDSCR). To examine the agreement of observed birth prevalence of Down's syndrome with the expected birth prevalence derived from published maternal age specific rates. Methods-The number of live births (adjusted to allow for the estimated underascertainment) and the number of terminations due to fetal Down's syndrome from NDSCR were compared with those figures reported to the ONS. Subsequently, using the NDSCR figures, the live birth prevalence of Down's syndrome that would have occurred in the absence of antenatal diagnosis and selective termination was calculated in England and Wales in the years 1990-1993. These figures were compared with those derived by applying published age specific prevalences to the maternal age distribution in England and Wales. Results-It is estimated that only 48% and 46% respectively of Down's syndrome live births and terminations of pregnancy were notified to ONS between 1990 and 1993. The annual expected birth prevalences of Down's syndrome obtained by applying maternal age specific prevalences to the maternal age distribution were in close agreement with observed rates from NDSCR.
Conclusions-There
is considerable underreporting of Down's syndrome births and terminations to ONS. The NDSCR data are more complete and therefore the effects of screening should be monitored using data from this source, or using estimates derived from the age specific rates of Down's syndrome. (Journal of Medical Screening 1997; 4:95-97) Keywords: Down's syndrome; birth prevalence Cytogenetic laboratories in England and Wales notify the National Down Syndrome Cyto-genetic Register (NDSCR) of diagnoses of the karyotype trisomy 21 or related anomalies. 1 The register contains details of an estimated 94% of all Down's syndrome live births,' and, it is thought, nearly all cytogenetically diagnosed terminations of pregnancy for Down's syndrome.' These data were used to assess the extent of underreporting to the Office for National Statistics (ONS) (formerly the Office of Population Censuses and Surveys) voluntary national congenital anomaly scheme. The number of births with Down's syndrome on the register, adjusted for underreporting, and the effect of antenatal diagnoses and subsequent terminations of pregnancy were also compared with the expected number obtained by applying published age specific rates of Down's syndrome to the age distribution of maternities in England and Wales.
Methods
The "background" live birth prevalence of Down's syndrome in residents of England and Wales in the calendar years 1990-93 was estimated using the NDSCR 4 with the number of live births in England and Wales as a denominator.' By "background" live birth prevalence, we mean the prevalence that would have occurred in the absence of antenatal diagnosis and selective termination. The NDSCR obtains diagnoses from all cytogenetic laboratories in England and Wales, and is therefore thought to be virtually complete with respect to cases of Down's syndrome when a full cytogenetic diagnosis has been obtained. Matching individual cases by region and date of birth with those reported to ONS yielded an estimated 6% underascertainment. The number of reported live births with Down's syndrome was increased by a factor of 1.06 to allow for this. To this number was added the number of pregnancies with Down's syndrome that were diagnosed antenatally and terminated, less a proportion (taken to be 23%)6 that would have been miscarried or ended in a stillbirth in the absence of selective termination. The figure of 23% was derived by comparing the prevalence of Down's syndrome in the second trimester obtained from routine amniocentesis offered on the basis of advanced maternal age (based on 610 cases of Down's Table 1 Prevalence of Down's syndrome as reported to the National Down Syndrome Cytogenetic Register, England and Wflles, 1990-1993 (6) Estimated (7) number of Down's (2) (3)
Down's syndrome Down's
Down's (4) syndrome Table 1 shows the estimated "background" birth prevalence of Down's syndrome based on notifications to the NDSCR for the years 1990-93. The rates were fairly constant from 1990 to 1992 and increased in 1993 (1.55 per 1000). Table 2 shows the estimated underreporting to ONS of Down's syndrome live births and terminations on the grounds of fetal Down's syndrome in England and Wales from 1990 to 1993. For the whole period combined, it is estimated that terminations of Down's syndrome fetuses and Down's syndrome births were underreported by 46% and 48% respectively. Table 3 shows the estimated number and prevalence of live births with Down's syndrome that would have occurred in the absence of antenatal diagnosis and termination of pregnancy derived from NDSCR, ONS, and by applying the age specific rates to the distribution of maternities. The ONS figures are again on average 48% lower than those from the NDSCR. The estimated prevalence from applying both the Hecht and Hook" and the Cuckle et al' age specific rates to the maternal age distribution of maternities are similar to those from the NDSCR (they varied from 1.4% lower to 3.4% higher for Hecht and Hook, and 2.8-8.7% lower for Cuckle et at). There has been an increase in the estimated (3) x (1-0.23) plus table 2 column (7) .
Results
:j:From expected Down's syndrome prevalence at each age x age distribution of maternities. ONS = Office for National Statistics; NDSCR = National Down Syndrome Cytogenetic Register; CI = confidence interval.
birth prevalence of Down's syndrome based on either set of age specific risk from 1990 to 1993 as women have tended to have their babies at an older age. This is reflected by the increased notification to the NDSCR in 1993.
Discussion
Evidence has been presented to show that the NDSCR, which receives details of diagnoses from all clinical cytogenetic laboratories in England and Wales, can be regarded as a valid method of ascertainment of Down's syndrome. 1 We have adjusted for the modest amount of underascertainment in the number of live births using the estimate obtained in previous work.' Using this method we estimated that Down's syndrome live births are underreported to ONS by an average of 48%, and legal terminations specifically on the grounds of fetal Down's syndrome are underreported to ONS by an average of 46% in the years 1990 to 1993. This is a similar proportion to the estimate of around 50% underreporting based on individual matching of details on the ONS form SD56 which notifies births with congenital anomalies diagnosed with details of Down's syndrome births reported to the NDSCR in the years 1991-94 (R Ide, personal communication). In England and Wales, the reporting of births with congenital anomalies is voluntary, but reporting legal terminations to the Chief Medical Officers for England and Wales is statutory under the 1967 Abortion Act. The underreporting of Down's syndrome live and stillbirths to ONS is partly due to notification being limited to diagnoses made less than 10 days after the birth, a limit that was removed in 1995. Some 6% of diagnoses of affected live births notified to the NDSCR occurred later than 10 days after birth. The underreporting of terminations is, in part, due to notifications with a diagnosis only of a chromosomal anomaly rather than specifically trisomy 21.
Estimations of the "background" birth prevalence of Down's syndrome based on the age specific Down's syndrome live birth rates from Cuckle et at' or Hecht and Hook" both yield birth prevalence figures within 10% of those observed (table 3) . Those estimates from Hecht and Hook" are marginally closer to those observed. Either set is acceptable in estimating the "background" number of Down's syndrome term pregnancies in a given population.
Our results show that the number of terminations of pregnancy on account of antenatal diagnosis reported by ONS needs to be multiplied by 1.85 (100/54) and the number of Down's syndrome births multiplied by 1.92 (100/52) to obtain correct estimates for the data in 1990-93. The lifting of the 10 day cut off for reporting malformations may improve the reporting rate by up to 6%, and needs to be investigated when more data are available. Since these ONS data are currently incomplete, the effects of antenatal screening should be monitored using data from the NDSCR, or using estimates derived from the age specific rates of Down's syndrome.
